+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Immunoassay Analyzers Market Size, Share & Trends Analysis Report by Analyzers (Enzyme Immunoassay (EIA) Analyzers, Radioimmunoassay (RIA) Analyzers), by End Use, and Segment Forecasts, 2021-2028

  • PDF Icon

    Report

  • 110 Pages
  • June 2021
  • Region: Europe
  • Grand View Research
  • ID: 5390501
The Europe immunoassay analyzers market size is expected to reach USD 2.6 billion by 2028. The market is expected to expand at a CAGR of 6.0% from 2021 to 2028. The rising prevalence of chronic and infectious diseases and the approval and launch of innovative analyzers are major factors driving the market.

The market is anticipated to exhibit significant growth due to the unprecedented COVID-19 pandemic leading to a shortage of diagnostics and infrastructure. This has created vast opportunities for companies operating in the marketplace to bridge the gap between supply and demand. Amid extensive funding in the healthcare sector, equally from public and private sectors, has led to several research projects pertaining to diagnostics, such as central laboratory tests and point of care tests. These initiatives are aiding in the development of tools, such as immunoassay analyzers. The consumption of immunoassays has increased tremendously during this period of a pandemic propelling the further market growth. The uncertainty over the longevity of the pandemic and the need for analyzers is expected to remain strong in the near future, thereby aiding regional growth.

In addition, increasing approval and launch of innovative and advanced analyzers in the key European countries has significantly boosted the market growth. For instance, in April 2021, Germany-based Siemens Healthineers received the CE Mark for its AtellicaVTLi Patient-Side Immunoassay Analyzer. This analyzer is capable of providing test results in 8 minutes to clinicians by utilizing a patient's blood sample. Furthermore, the entrance of leading players in the European region is further expected to create increased access to advanced products. For instance, in February 2021, SysmexCorporation, a Japan-based immunoassay manufacturer, established its new subsidiary, Sysmex Portugal, S.A., in Portugal. With this initiative, the company expanded its presence in Portugal by intensifying its sales and after-sales support networks.

Europe Immunoassay Analyzers Market Report Highlights

  • The EIA analyzers segment held the largest revenue share in the market as this technique is used for detecting specific antigens or antibodies in samples
  • By end use, the hospitals segment held the largest revenue share in 2020, as hospitals are the primary centers for the diagnosis and treatment of chronic diseases
  • The clinical laboratories segment is anticipated to grow at a rapid pace over the forecast period owing to the increasing establishment of diagnostic labs in key countries
  • Germany was the largest market in 2020 due to well-established healthcare infrastructure and high adoption of technologically advanced products
  • In the U.K., the market is anticipated to exhibit the fastest growth over the forecast period due to the growing prevalence of chronic diseases and the geriatric population


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Market definition
1.3 Information procurement
1.3.1 Purchased database
1.3.2 Internal database
1.3.3 Secondary sources & third party perspectives
1.3.4 Primary research
1.4 Information analysis
1.4.1 Data analysis models
1.5 Market formulation & data visualization
1.6 Data validation & publishing
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 Europe Immunoassay Analyzers Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration and Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Rising incidence of chronic and infectious diseases
3.3.1.2 Growing demand for automated immunoassay analyzers
3.3.1.3 Increase in research activities in biotech and pharma industries
3.3.2 Market Restraint Analysis
3.3.2.1 Limitations associated with immunoassay techniques
3.3.2.2 High costs of automated analyzers
3.3.3 Industry challenges
3.3.4 COVID-19 Impact Analysis
3.4 Europe Immunoassay Analyzers Market Analysis Tools
3.4.1 Industry analysis - Porter’s
3.4.1.1 Supplier Power
3.4.1.2 Buyer Power
3.4.1.3 Substitution Threat
3.4.1.4 Threat from new entrants
3.4.1.5 Competitive Rivalry
3.4.2 PESTEL Analysis
3.4.2.1 Political Landscape
3.4.2.2 Environmental Landscape
3.4.2.3 Social landscape
3.4.2.4 Technology landscape
3.4.2.5 Legal Landscape
Chapter 4 Europe Immunoassay Analyzers Market - Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Vendor Landscape
4.2.1 List of Major Suppliers/Distributors/Manufacturers, By Country
4.3 Public Companies
4.3.1 Company market position analysis
4.3.2 Competitive dashboard analysis
4.4 Private Companies
4.4.1 List of key emerging companies
4.4.2 Country network map
4.4.3 Company market position analysis
Chapter 5 Europe Immunoassay Analyzers Market: Analyzers Estimates and Trend Analysis
5.1 Definition & Scope
5.2 Analyzers Market Share Analysis, 2020 & 2028
5.3 Segment Dashboard
5.4 Europe Immunoassay Analyzers Market, by Analyzers, 2016 to 2028
5.5 Market Size & Forecasts and Trend Analyses, 2016 to 2028
5.5.1 Enzyme Immunoassay (EIA) Analyzers
5.5.1.1 Enzyme Immunoassay (EIA) Analyzers Market Estimates and Forecasts, 2016 to 2028 (USD Million)
5.5.1.2 Chemiluminescence Immunoassay (CLIA) Analyzers
5.5.1.2.1 Chemiluminescence Immunoassay (CLIA) Analyzers Market Estimates and Forecasts, 2016 to 2028 (USD Million)
5.5.1.3 Fluorescence Immunoassay (FIA) Analyzers
5.5.1.3.1 Fluorescence Immunoassay Analyzers (FIA) Market Estimates and Forecasts, 2016 to 2028 (USD Million)
5.5.2 Radioimmunoassay (RIA) Analyzers
5.5.2.1 Radioimmunoassay (RIA) Analyzers Market Estimates and Forecasts, 2016 to 2028 (USD Million)
5.5.3 Others Analyzers
5.5.3.1 Others Analyzers Market Estimates and Forecasts, 2016 to 2028 (USD Million)
Chapter 6 Europe Immunoassay Analyzers Market: End Use Estimates and Trend Analysis
6.1 Definition & Scope
6.2 End-use Market Share Analysis, 2020 & 2028
6.3 Segment Dashboard
6.4 Europe Immunoassay Analyzers Market, By End Use, 2016 to 2028
6.5 Market Size & Forecasts and Trend Analyses, 2016 to 2028
6.5.1 Hospitals
6.5.1.1 Hospitals Market Estimates and Forecasts, 2016 to 2028 (USD Million)
6.5.2 Blood Banks
6.5.2.1 Blood Banks Market Estimates and Forecasts, 2016 to 2028 (USD Million)
6.5.3 Clinical Laboratories
6.5.3.1 Clinical Laboratories Market Estimates and Forecasts, 2016 to 2028 (USD Million)
6.5.4 Pharmaceutical and Biotech Companies
6.5.4.1 Pharmaceutical and Biotech Companies Market Estimates and Forecasts, 2016 to 2028 (USD Million)
6.5.5 Academic Research Centers
6.5.5.1 Academic Research Centers Market Estimates and Forecasts, 2016 to 2028 (USD Million)
6.5.6 Others
6.5.6.1 Others Market Estimates and Forecasts, 2016 to 2028 (USD Million)
Chapter 7 Europe Immunoassay Analyzers Market: Country Estimates & Trend Analysis
7.1 Regional Market Snapshot
7.2 Regional Market Share and Leading Players, 2020
7.3 Market Share Analysis by Country, 2020
7.3.1 Germany
7.3.2 U.K.
7.3.3 France
7.3.4 Italy
7.3.5 Spain
7.3.6 Russia
7.3.7 Belgium
7.3.8 Switzerland
7.3.9 Netherlands
7.3.10 Poland
7.3.11 Austria
7.3.12 Greece
7.3.13 Sweden
7.3.14 Finland
7.4 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.5 Market Size & Forecasts, and Trend Analysis, 2020 to 2028
7.5.1 Europe
7.5.1.1 Europe Market Size & Forecasts and Trend Analysis, 2016 to 2028 (USD Million)
7.5.1.2 U.K.
7.5.1.2.1 U.K. Market Size & Forecasts and Trend Analysis, By Analyzers, 2016 to 2028 (USD Million)
7.5.1.2.2 U.K. Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD Million)
7.5.1.3 Germany
7.5.1.3.1 Germany Market Size & Forecasts and Trend Analysis, By Analyzers, 2016 to 2028 (USD Million)
7.5.1.3.2 Germany Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD Million)
7.5.1.4 Spain
7.5.1.4.1 Spain Market Size & Forecasts and Trend Analysis, By Analyzers, 2016 to 2028 (USD Million)
7.5.1.4.2 Spain Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD Million)
7.5.1.5 France
7.5.1.5.1 France Market Size & Forecasts and Trend Analysis, By Analyzers, 2016 to 2028 (USD Million)
7.5.1.5.2 France Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD Million)
7.5.1.6 Italy
7.5.1.6.1 Italy Market Size & Forecasts and Trend Analysis, By Analyzers, 2016 to 2028 (USD Million)
7.5.1.6.2 Italy Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD Million)
7.5.1.7 Russia
7.5.1.7.1 Russia Market Size & Forecasts and Trend Analysis, By Analyzers, 2016 to 2028 (USD Million)
7.5.1.7.2 Russia Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD Million)
7.5.1.8 Belgium
7.5.1.8.1 Belgium Market Size & Forecasts and Trend Analysis, By Analyzers, 2016 to 2028 (USD Million)
7.5.1.8.2 Belgium Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD Million)
7.5.1.9 Switzerland
7.5.1.9.1 Switzerland Market Size & Forecasts and Trend Analysis, By Analyzers, 2016 to 2028 (USD Million)
7.5.1.9.2 Switzerland Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD Million)
7.5.1.10 Netherlands
7.5.1.10.1 Netherlands Market Size & Forecasts and Trend Analysis, By Analyzers, 2016 to 2028 (USD Million)
7.5.1.10.2 Netherlands Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD Million)
7.5.1.11 Poland
7.5.1.11.1 Poland Market Size & Forecasts and Trend Analysis, By Analyzers, 2016 to 2028 (USD Million)
7.5.1.11.2 Poland Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD Million)
7.5.1.12 Austria
7.5.1.12.1 Austria Market Size & Forecasts and Trend Analysis, By Analyzers, 2016 to 2028 (USD Million)
7.5.1.12.2 Austria Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD Million)
7.5.1.13 Greece
7.5.1.13.1 Greece Market Size & Forecasts and Trend Analysis, By Analyzers, 2016 to 2028 (USD Million)
7.5.1.13.2 Greece Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD Million)
7.5.1.14 Sweden
7.5.1.14.1 Sweden Market Size & Forecasts and Trend Analysis, By Analyzers, 2016 to 2028 (USD Million)
7.5.1.14.2 Sweden Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD Million)
7.5.1.15 Finland
7.5.1.15.1 Finland Market Size & Forecasts and Trend Analysis, By Analyzers, 2016 to 2028 (USD Million)
7.5.1.15.2 Finland Market Size & Forecasts and Trend Analysis, By End Use, 2016 to 2028 (USD Million)
Chapter 8 Company Profiles
8.1 Company Profiles
8.1.1 Siemens Healthineers
8.1.1.1 Company overview
8.1.1.2 Financial Performance
8.1.1.3 Product benchmarking
8.1.1.4 Strategic initiatives
8.1.2 bioMérieux SA
8.1.2.1 Company overview
8.1.2.2 Financial Performance
8.1.2.3 Product benchmarking
8.1.2.4 Strategic initiatives
8.1.3 Abbott Laboratories
8.1.3.1 Company overview
8.1.3.2 Financial Performance
8.1.3.3 Product benchmarking
8.1.3.4 Strategic initiatives
8.1.4 Danaher Corporation (Beckman Coulter)
8.1.4.1 Company overview
8.1.4.2 Financial Performance
8.1.4.3 Product benchmarking
8.1.4.4 Strategic initiatives
8.1.5 Quidel Corporation
8.1.5.1 Company overview
8.1.5.2 Financial Performance
8.1.5.3 Product benchmarking
8.1.5.4 Strategic initiatives
8.1.6 Ortho Clinical Diagnostics
8.1.6.1 Company overview
8.1.6.2 Financial Performance
8.1.6.3 Product benchmarking
8.1.6.4 Strategic initiatives
8.1.7 Sysmex Corporation
8.1.7.1 Company overview
8.1.7.2 Financial Performance
8.1.7.3 Product benchmarking
8.1.7.4 Strategic initiatives
8.1.8 Bio-Rad Laboratories, Inc.
8.1.8.1 Company overview
8.1.8.2 Financial Performance
8.1.8.3 Product benchmarking
8.1.8.4 Strategic initiatives
8.1.9 Becton, Dickinson and Company
8.1.9.1 Company overview
8.1.9.2 Financial Performance
8.1.9.3 Product benchmarking
8.1.9.4 Strategic initiatives
8.1.10 F. Hoffmann-La Roche AG
8.1.10.1 Company overview
8.1.10.2 Financial Performance
8.1.10.3 Product benchmarking
8.1.10.4 Strategic initiatives
8.1.11 Thermo Fisher Scientific, Inc.
8.1.11.1 Company overview
8.1.11.2 Financial Performance
8.1.11.3 Product benchmarking
8.1.11.4 Strategic initiatives
List of Tables
Table 1 List of key distributors and channel partners
Table 2 List of key emerging companies’/technology disruptors/innovators
Table 3 Europe immunoassay analyzers market, by country, 2016 - 2028 (USD Million)
Table 4 Europe immunoassay analyzers market, by analyzers, 2016 - 2028 (USD Million)
Table 5 Europe immunoassay analyzers market, by enzyme immunoassay (EIA) analyzers, 2016 - 2028 (USD Million)
Table 6 Europe immunoassay analyzers market, by end use, 2016 - 2028 (USD Million)
Table 7 Germany immunoassay analyzers market, by analyzers, 2016 - 2028 (USD Million)
Table 8 Germany immunoassay analyzers market, by enzyme immunoassay (EIA) analyzers, 2016 - 2028 (USD Million)
Table 9 Germany immunoassay analyzers market, by end use, 2016 - 2028 (USD Million)
Table 10 U.K. immunoassay analyzers market, by analyzers, 2016 - 2028 (USD Million)
Table 11 U.K. immunoassay analyzers market, by enzyme immunoassay (EIA) analyzers, 2016 - 2028 (USD Million)
Table 12 U.K. immunoassay analyzers market, by end use, 2016 - 2028 (USD Million)
Table 13 France immunoassay analyzers market, by analyzers, 2016 - 2028 (USD Million)
Table 14 France immunoassay analyzers market, by enzyme immunoassay (EIA) analyzers, 2016 - 2028 (USD Million)
Table 15 France immunoassay analyzers market, by end use, 2016 - 2028 (USD Million)
Table 16 Spain immunoassay analyzers market, by analyzers, 2016 - 2028 (USD Million)
Table 17 Spain immunoassay analyzers market, by enzyme immunoassay (EIA) analyzers, 2016 - 2028 (USD Million)
Table 18 Spain immunoassay analyzers market, by end use, 2016 - 2028 (USD Million)
Table 19 Italy immunoassay analyzers market, by analyzers, 2016 - 2028 (USD Million)
Table 20 Italy immunoassay analyzers market, by enzyme immunoassay (EIA) analyzers, 2016 - 2028 (USD Million)
Table 21 Italy immunoassay analyzers market, by end use, 2016 - 2028 (USD Million)
Table 22 Russia immunoassay analyzers market, by analyzers, 2016 - 2028 (USD Million)
Table 23 Russia immunoassay analyzers market, by enzyme immunoassay (EIA) analyzers, 2016 - 2028 (USD Million)
Table 24 Russia immunoassay analyzers market, by end use, 2016 - 2028 (USD Million)
Table 25 Belgium immunoassay analyzers market, by analyzers, 2016 - 2028 (USD Million)
Table 26 Belgium immunoassay analyzers market, by enzyme immunoassay (EIA) analyzers, 2016 - 2028 (USD Million)
Table 27 Belgium immunoassay analyzers market, by end use, 2016 - 2028 (USD Million)
Table 28 Switzerland immunoassay analyzers market, by analyzers, 2016 - 2028 (USD Million)
Table 29 Switzerland immunoassay analyzers market, by enzyme immunoassay (EIA) analyzers, 2016 - 2028 (USD Million)
Table 30 Switzerland immunoassay analyzers market, by end use, 2016 - 2028 (USD Million)
Table 31 Netherlands immunoassay analyzers market, by analyzers, 2016 - 2028 (USD Million)
Table 32 Netherlands immunoassay analyzers market, by enzyme immunoassay (EIA) analyzers, 2016 - 2028 (USD Million)
Table 33 Netherlands immunoassay analyzers market, by end use, 2016 - 2028 (USD Million)
Table 34 Poland immunoassay analyzers market, by analyzers, 2016 - 2028 (USD Million)
Table 35 Poland immunoassay analyzers market, by enzyme immunoassay (EIA) analyzers, 2016 - 2028 (USD Million)
Table 36 Poland immunoassay analyzers market, by end use, 2016 - 2028 (USD Million)
Table 37 Austria immunoassay analyzers market, by analyzers, 2016 - 2028 (USD Million)
Table 38 Austria immunoassay analyzers market, by enzyme immunoassay (EIA) analyzers, 2016 - 2028 (USD Million)
Table 39 Austria immunoassay analyzers market, by end use, 2016 - 2028 (USD Million)
Table 40 Greece immunoassay analyzers market, by analyzers, 2016 - 2028 (USD Million)
Table 41 Greece immunoassay analyzers market, by enzyme immunoassay (EIA) analyzers, 2016 - 2028 (USD Million)
Table 42 Greece immunoassay analyzers market, by end use, 2016 - 2028 (USD Million)
Table 43 Sweden immunoassay analyzers market, by analyzers, 2016 - 2028 (USD Million)
Table 44 Sweden immunoassay analyzers market, by enzyme immunoassay (EIA) analyzers, 2016 - 2028 (USD Million)
Table 45 Sweden immunoassay analyzers market, by end use, 2016 - 2028 (USD Million)
Table 46 Finland immunoassay analyzers market, by analyzers, 2016 - 2028 (USD Million)
Table 47 Finland immunoassay analyzers market, by enzyme immunoassay (EIA) analyzers, 2016 - 2028 (USD Million)
Table 48 Finland immunoassay analyzers market, by end use, 2016 - 2028 (USD Million)
List of Figures
Fig. 1 Europe immunoassay analyzers market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 Europe immunoassay analyzers market snapshot (2020)
Fig. 9 Europe immunoassay analyzers market: Segment snapshot (2020)
Fig. 10 Competitive Insights (2020)
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Europe immunoassay analyzers market driver impact
Fig. 15 Europe immunoassay analyzers market restraint impact
Fig. 16 Europe immunoassay analyzers market industry challenges
Fig. 17 Porter’s Five Forces Analysis
Fig. 18 SWOT Analysis, By Factor (Political & legal Economic and technological)
Fig. 19 Strategic alliance analysis
Fig. 20 Recent developments & impact analysis, by key market participants
Fig. 21 Key company market share analysis, 2020
Fig. 22 Company market position analysis
Fig. 23 Definition and scope, by analyzers
Fig. 24 Analyzers market share analysis, 2020 & 2028
Fig. 25 Segment dashboard
Fig. 26 Europe immunoassay analyzers market, by analyzers, 2016 - 2028 (USD Million)
Fig. 27 Enzyme Immunoassay (EIA) analyzers market size & forecasts and trend analysis, 2016 to 2028 (USD Million)
Fig. 28 Chemiluminescence Immunoassay (CLIA) analyzers market size & forecasts and trend analysis, 2016 to 2028 (USD Million)
Fig. 29 Fluorescence immunoassay (FIA) analyzers market size & forecasts and trend analysis, 2016 to 2028 (USD Million)
Fig. 30 Radioimmunoassay (RIA) analyzers market size & forecasts and trend analysis, 2016 to 2028 (USD Million)
Fig. 31 Others analyzers market size & forecasts and trend analysis, 2016 to 2028 (USD Million)
Fig. 32 Definition and scope, by end use
Fig. 33 End-use market share analysis, 2020 & 2028
Fig. 34 Segment dashboard
Fig. 35 Europe immunoassay analyzers market, by end use, 2016 - 2028 (USD Million)
Fig. 36 Hospitals market size & forecasts and trend analysis, 2016 to 2028 (USD Million)
Fig. 37 Blood banks market size & forecasts and trend analysis, 2016 to 2028 (USD Million)
Fig. 38 Clinical Laboratories market size & forecasts and trend analysis, 2016 to 2028 (USD Million)
Fig. 39 Pharmaceutical and Biotechnology Companies market size & forecasts and trend analysis, 2016 to 2028 (USD Million)
Fig. 40 Academic Research Centers market size & forecasts and trend analysis, 2016 to 2028 (USD Million)
Fig. 41 Others market size & forecasts and trend analysis, 2016 to 2028 (USD Million)
Fig. 42 Europe immunoassay analyzers market: Snapshot, 2020
Fig. 43 Europe immunoassay analyzers market share and leading players, 2020
Fig. 44 Europe market share analysis by country, 2020
Fig. 45 Europe SWOT analysis, by factor (political & legal, economic and technological)
Fig. 46 U.K. market size, & forecasts and trend analysis, 2016 to 2028 (USD Million)
Fig. 47 Germany market size, & forecasts and trend analysis, 2016 to 2028 (USD Million)
Fig. 48 Spain market size, & forecasts and trend analysis, 2016 to 2028 (USD Million)
Fig. 49 France market size, & forecasts and trend analysis, 2016 to 2028 (USD Million)
Fig. 50 Italy market size, & forecasts and trend analysis, 2016 to 2028 (USD Million)
Fig. 51 Russia market size, & forecasts and trend analysis, 2016 to 2028 (USD Million)
Fig. 52 Belgium market size, & forecasts and trend analysis, 2016 to 2028 (USD Million)
Fig. 53 Switzerland market size, & forecasts and trend analysis, 2016 to 2028 (USD Million)
Fig. 54 Netherlands market size, & forecasts and trend analysis, 2016 to 2028 (USD Million)
Fig. 55 Poland market size, & forecasts and trend analysis, 2016 to 2028 (USD Million)
Fig. 56 Austria market size, & forecasts and trend analysis, 2016 to 2028 (USD Million)
Fig. 57 Greece market size, & forecasts and trend analysis, 2016 to 2028 (USD Million)
Fig. 58 Sweden market size, & forecasts and trend analysis, 2016 to 2028 (USD Million)
Fig. 59 Finland market size, & forecasts and trend analysis, 2016 to 2028 (USD Million)

Companies Mentioned

  • Siemens Healthineers
  • bioMérieux SA
  • Abbott Laboratories
  • Danaher Corporation (Beckman Coulter)
  • Quidel Corporation
  • Ortho Clinical Diagnostics
  • Sysmex Corporation
  • Bio-Rad Laboratories, Inc.
  • Becton, Dickinson and Company
  • F. Hoffmann-La Roche AG
  • Thermo Fisher Scientific, Inc.

Methodology

Loading
LOADING...

Table Information